|Articles|October 15, 2013
Structural Forces Impacting the Pharmaceutical Industry
Patrick Lindsay, president of UBC sits down with Editorial Director William Looney to discusses the issues UBC confronts as it offers support services to pharmaceutical companies
Advertisement
Patrick Lindsay, president of UBC sits down with Editorial Director Bill Loony to discusses the issues UBC confronts as it offers support services to pharmaceutical companies.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma and MedTech Rarely Collide. That Might Be the Biggest Miss in Healthcare
2
Insilico Medicine Enters $120 Million Drug Development Collaboration with Qilu Pharmaceuticals to Advance Cardiometabolic Therapies
3
Public Citizen Files Suit Against Trump Administration for Undisclosed Details of Pfizer and Eli Lilly Drug-Pricing Deals: Report
4
FDA Approves Yuvezzi to Treat Presbyopia in Adults
5